The role of ZEB1 in the inflammation-induced promotion of EMT in HNSCC
The role of ZEB1 in the inflammation-induced promotion of EMT in HNSCC
复制标题
DOI:
10.1016/j.otohns.2010.01.034
复制
发表时间:
2010-05-01
影响因子:
3.4
通讯作者:
John, Maie A. St.
中科院分区:
文献类型:
--
作者:
Dohadwala, Mariam;Wang, Guanyu;John, Maie A. St.
OBJECTIVES: To determine the role of ZEB1 in the inflammation-induced promotion of the epithelial-mesenchymal transition (EMT) in head and neck squamous cell carcinoma (HNSCC).STUDY DESIGN: A molecular biology study. Real-time quantitative reverse-transcriptase polymerase chain reaction (RT-PCR), Western blot analysis, and immunohistochemical staining of human HNSCC tissue sections were used to determine how inflammation affects the transcriptional repressor, ZEB1.SETTING: An academic hospital laboratory.SUBJECTS AND METHODS: Relative ZEB1 RNA levels were determined by RT-PCR, and protein expression was evaluated in situ by immunohistochemical staining of human HNSCC tissue sections.RESULTS: IL-1 beta-treated HNSCC cell lines demonstrated a significant decrease in E-cadherin mRNA and an increase in the mRNA expression of the transcriptional repressor ZEB1. IL-1 beta exposure led to enhanced ZEB1 binding at the chromatin level, as determined by chromatin immunoprecipitation assays (ChIP). An inverse relationship between ZEB1 and E-cadherin was demonstrated in situ by immunohistochemical staining of human HNSCC tissue sections.CONCLUSIONS: Our recent investigations indicate that inflammatory mediators are potent regulators of EMT in HNSCC. This is the first report indicating the role of ZEB1 in the inflammation-induced promotion of EMT in HNSCC. This newly defined pathway for transcriptional regulation of E-cadherin in HNSCC has important implications for targeted chemoprevention and therapy. (C) 2010 American Academy of Otolaryngology Head and Neck Surgery Foundation. All rights reserved.